The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 2, 2012, Pages 613-621

  Schramm, Charlotte ^a   Spitzer, Martin S ^a   Henke Fahle, Sigrid ^a   Steinmetz, Gabriele ^a   Januschowski, Kai ^a   Heiduschka, Peter ^a   Geis Gerstorfer, Jürgen ^b   Biedermann, Tilo ^c   Bartz Schmidt, Karl U ^a   Szurman, Peter ^a  

^a Department of Ophthalmology   (Germany)

^b Oral Medicine and Maxillofacial Surgery   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; 1 VINYL 2 PYRROLIDINONE; HYALURONIC ACID; URONIC ACID; BIOMATERIAL; BIOPOLYMER; CROSS LINKING REAGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CARBOXYLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORNEA OPACITY; CROSS LINKING; CYTOTOXICITY TEST; DEGRADATION; ELECTRORETINOGRAPHY; FLOW CYTOMETRY; FLOW KINETICS; HUMAN; HUMAN CELL; HYDROGEL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; REFRACTION INDEX; ULTRAVIOLET RADIATION; VISCOELASTICITY; VISCOSITY; VISUAL PROSTHESIS; VITREOUS BODY; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; EYE; MATERIALS TESTING; METABOLISM; PROSTHESES AND ORTHOSES;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; CROSS-LINKING REAGENTS; EYE; HUMANS; HYALURONIC ACID; HYDROGELS; MATERIALS TESTING; PROSTHESES AND IMPLANTS; RABBITS; VISCOSITY; VITREOUS BODY;

EID: 84858990587     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7322     Document Type: Article

References (39)

1. Foster WJ. Vitreous substitutes. Expert Rev Ophthalmol. 2008; 3(2):211-218.
2. Spitzer MS, Kaczmarek RT, Yoeruek E, et al. The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil. Invest Ophthalmol Vis Sci. 2009; 50(5):2337-2343.
3. Lewis H, Aaberg TM, Abrams GW. Cause of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. AMJ Ophthalmol. 1991;111:8-14.
4. Mackiewics J, Mühling B, Hiebl W, et al. In vivo retinal tolerances of various heavy silicone oils. Invest Ophthalmol Vis Sci. 2007; 48(4):1873-1883.
5. Nakagawa M, Tanaka M, Miyata T. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes. Ophthalmic Res. 1997;29: 409-420.
6. Pruett RC, Schepens CL, Swann DA. Hyaluronic acid vitreous substitute; a six-year clinical evaluation. Arch Ophthalmol. 1979; 97(12):2325-2330.
7. Swindle KE, Ravi N. Recent advances in polymeric vitreous substitutes. Expert Rev Ophthalmol. 2007;2:255-265.
8. Chirila TV, Tahija S, Hong Y, et al. Synthetic polymers as materials for artificial vitreous body: review and recent advances. J Biomater Appl. 1994;9(2):121-137.
9. Hong Y, Chirila TV, Vijayasekaran S, et al. Crosslinked poly(1-vinyl- 2-pyrrolidinone) as a vitreous substitute. J Biomed Mater Res. 1996;30(4):441-448.
10. Hong Y, Chirila TV, Vijayasekaran S, et al. Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res. 1998;39(4):650-659.
11. Soman N, Banerjee R. Artificial vitreous replacements. Biomed Mater Eng. 2003;13(1):59-74.
12. Balazs EA. Fine structure and function of ocular tissues. the vitreous. Int Ophthalmol Clin. 1974;13(3):169-187.
13. Eisner G. Zur Anatomie des Glaskörpers. Graefes Arch. 1975;193: 33-56.
14. Hascall VC. Hyaluronan, a common thread. Glycoconj J. 2000;17 (7-9):607-616.
15. Kakehi K, Kinoshita M, Yasueda S. Hyaluronic acid: separation and biological implications. J Chromatogr B. 2003;797:347-355.
16. Prestwich GD, Marecak DM, Marecek JF, et al. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. J Control Release. 1998; 53(1-3):93-103.
17. Vercruysse KP, Marecak DM, Marecek JF, Prestwich GD. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Biokonjugate Chem. 1997;8:686-694.
18. Leach JB, Bivens KA, Patrick CW Jr, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng. 2003;82(5):578-589.
19. Leach JB, Bivens KA, Collins CN, Schmidt CE. Development of photocrosslinkable hyaluronic acid-polyethylene glycol-peptide composite hydrogels for soft tissue engineering. J Biomed Mater Res A. 2004;70(1):74-82.
20. Bitter T, Muir HM. A modified uronic acid carbazole reaction, Anal Biochem. 1962;4:330-334.
21. Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body, Part 1: viscoelasticity of human vitreous. Biorheology. 1992;29:521-533.
22. Lee B, Litt M, Buchsbaum G. Rheology of the vitreous body, Part 2: viscoelasticity of bovine and porcine vitreous. Biorheology. 1994; 31:327-338.
23. Foster WJ, Aliyar HA, Hamilton P, et al. Internal osmotic pressure as a mechanism of retinal attachment in a vitreous substitute. J Bioact Compat Polym. 2006;21:221-235.
24. Silver FH, LiBrizzi J, Benedetto D. Use of viscoelastic solutions in ophthalmology: a review of physical properties and longterm effects. J Long Term Eff Med Implants. 1992;2(1):49-66.
25. Theelen T, Tilanus MAD, Klevering BJ. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol. 2004;242:617-620.
26. Kirchhof B, Tavakolian U, Paulmann H, et al. Histopathological findings in eyes after silicon oil injection. Graefes Arch Clin Exp Ophthalmol. 1986;224:34-37.
27. Szurman P, Frank C, Kaczmarek RT, et al. Vitreous substitutes as drug release systems (in German). Klin Monbl Augenheilkd. 2009; 226:718-724.
28. Cho KY, Chung TW, Kim BC, et al. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int J Pharm. 2003;260(1):83-91.
29. Kelly RM, Meyer JD, Matsuura JE, et al. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm. 1999;25(1):15-20.
30. Liesegang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol. 1990;34(4):268-293.
31. Koster R, Stilma JS. Healon as intravitreal substitute in retinal detachment surgery in 40 patients. Doc Ophthalmol. 1986;64(1): 13-17.
32. Su WY, Chen KH, Chen YC, et al. An injectable oxidated hyaluronic acid/adipic acid dihydrazide hydrogel as a vitreous substitute. J Biomater Sci Polym Ed. 2011;22:1777-1797.
33. Nguyen KT, West JL. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials. 2002;23;4307-4314.
34. Swindle-Reilly KE, Shah M, Hamilton PD. Rabbit study of an in situ formin hydrogel vitreous substitute. Invest Ophthalmol Vis Sci. 2009;50:4840-4846.
35. Hotta K, Sugitani A. Refractive changes in silicone oil-filled pseudophakic eyes. Retina. 2005;25(2):167-170.
36. D-Errico G, De Lellis M, Mangiapia G, et al. Structural and mechanical properties of UV-photo-crosslinked poly(n-vinyl-2-pyrrolidone) hydrogels. Biomacromolecules. 2008;9:231-240.
37. Pritchard CD, Crafoord S, Andréasson S, et al. Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits. Acta Biomater. 2011; 7:936-943.
38. Segura T, Anderson BC, Chung PH, et al. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials. 2005;26(4):359-371.
39. Roldán-Pallarés M, Hernández-Montero J, Llanes F, et al. MIRAgel: hydrolytic degradation and long-term observations. Arch Ophthalmol.2007;125:511-514.